Selinexor for multiple myeloma receives accelerated FDA approval

by H. Lee Moffitt Cancer Center & Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-in-class d

Updated on: May 09,2024

Selinexor for multiple myeloma receives accelerated FDA approval

by H. Lee Moffitt Cancer Center & Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A first-in-class d

Updated on:May 09,2024

Repurposing FDA-approved drugs can help fight back breast cancer

by Baylor College of MedicineMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaScreening Food and Dr

Updated on: April 07,2024

Repurposing FDA-approved drugs can help fight back breast cancer

by Baylor College of MedicineMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaScreening Food and Dr

Updated on:April 07,2024

Colorectal cancer: Tipping the scales

by Ludwig Maximilian University of MunichMicrograph of an organoids, which were generated from intestinal epithelial cells cultered ex vivo. Ap4-deficient organoids formed less protrusions/crypts

Updated on: March 01,2024

Colorectal cancer: Tipping the scales

by Ludwig Maximilian University of MunichMicrograph of an organoids, which were generated from intestinal epithelial cells cultered ex vivo. Ap4-deficient organoids formed less protrusions/crypts

Updated on:March 01,2024

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on: February 18,2024

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on:February 18,2024

Team develops effective cigar warning signage

byUniversity of North Carolina at Chapel Hill School of MedicineStimuli for the experimental conditions. Participants saw an image of a cigar store countertop at the point-of-sale with randomiza

Updated on: January 08,2024

Team develops effective cigar warning signage

byUniversity of North Carolina at Chapel Hill School of MedicineStimuli for the experimental conditions. Participants saw an image of a cigar store countertop at the point-of-sale with randomiza

Updated on:January 08,2024

Immune cell helps predict skin cancer patients' chances of responding to treatment

byKing's College Londona, Schematic of nonenzymatic extraction of lymphocytes from primary human tissue and subsequent expansion protocol. b, Summary flow cytometry data of Vδ1+cell en

Updated on: January 26,2024

Immune cell helps predict skin cancer patients' chances of responding to treatment

byKing's College Londona, Schematic of nonenzymatic extraction of lymphocytes from primary human tissue and subsequent expansion protocol. b, Summary flow cytometry data of Vδ1+cell en

Updated on:January 26,2024

Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResearchers identified a higher rate of clonal hematopoiesis (CH) and prevalence of treatment-induced STAT3 gene mutat

Updated on: December 28,2023

Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResearchers identified a higher rate of clonal hematopoiesis (CH) and prevalence of treatment-induced STAT3 gene mutat

Updated on:December 28,2023

Global study predicts more than 50 percent rise in chemotherapy demand by 2040

byLancetCredit: CC0 Public DomainTo deliver optimal treatment by 2040, a significant expansion of the chemotherapy workforce is needed.Between 2018 and 2040, the number of patients requiri

Updated on: May 23,2024

Global study predicts more than 50 percent rise in chemotherapy demand by 2040

byLancetCredit: CC0 Public DomainTo deliver optimal treatment by 2040, a significant expansion of the chemotherapy workforce is needed.Between 2018 and 2040, the number of patients requiri

Updated on:May 23,2024

Mutation-specific peptide vaccine against midline gliomas used in patients for the first time

by German Cancer Research CenterCredit: Pixabay/CC0 Public DomainTumor vaccines can help the body fight cancer. These vaccines alert the patient's immune system to proteins that are carrying

Updated on: April 14,2024

Mutation-specific peptide vaccine against midline gliomas used in patients for the first time

by German Cancer Research CenterCredit: Pixabay/CC0 Public DomainTumor vaccines can help the body fight cancer. These vaccines alert the patient's immune system to proteins that are carrying

Updated on:April 14,2024

Team identifies key driver of cancer cell death pathway that activates immune cells

by University of Illinois at Urbana-ChampaignThe research team included, from left, research scientist Chengjian Mao, graduate student Xinyi Dai, biochemistry professor David Shapiro, graduate st

Updated on: February 23,2024

Team identifies key driver of cancer cell death pathway that activates immune cells

by University of Illinois at Urbana-ChampaignThe research team included, from left, research scientist Chengjian Mao, graduate student Xinyi Dai, biochemistry professor David Shapiro, graduate st

Updated on:February 23,2024

Antitumor cell activity in glioblastoma regulated by inhibiting triggering receptor expressed on myeloid cells 2

by Thamarasee Jeewandara , Medical XpressTREM2 expression is higher in GBM tumors than normal brain tissue and inversely correlates with patient outcome. (A) Box plots of TREM2 expression in IDH1/2–wi

Updated on: February 24,2024

Antitumor cell activity in glioblastoma regulated by inhibiting triggering receptor expressed on myeloid cells 2

by Thamarasee Jeewandara , Medical XpressTREM2 expression is higher in GBM tumors than normal brain tissue and inversely correlates with patient outcome. (A) Box plots of TREM2 expression in IDH1/2–wi

Updated on:February 24,2024

Mammogram rates increase after ACA eliminates co-payments

by Brown UniversityCredit: CC0 Public DomainAfter the Affordable Care Act (ACA) eliminated cost sharing for screening mammograms, their rate of use rose six percentage points among older woman fo

Updated on: March 27,2024

Mammogram rates increase after ACA eliminates co-payments

by Brown UniversityCredit: CC0 Public DomainAfter the Affordable Care Act (ACA) eliminated cost sharing for screening mammograms, their rate of use rose six percentage points among older woman fo

Updated on:March 27,2024